ESC Premium Access

Efficacy and safety of inclisiran in patients with polyvascular disease: pooled, post hoc analysis of the ORION-9, ORION-10 and ORION-11, phase 3 randomised controlled trials

Congress Session

About the speaker

Professor Wolfgang Koenig

German Heart Center of Munich, Munich (Germany)
23 presentations
0 follower

1 more presentation in this session

A view to the future: approach to vulnerable plaque and/or vulnerable patients

Speaker: Professor R. Byrne (Dublin, IE)

Thumbnail

Access the full session

Evolving frontiers for coronary artery disease

Speakers: Professor W. Koenig, Professor R. Byrne
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

ACNAP Premium Access

Discussion: Shared decision-making: how, what, and why.

23 May 2022

EHRA Premium Access

Effectiveness and safety of edoxaban in 27,333 patients from ETNA-AF with and without a history of intracranial haemorrhage after 2 years of treatment

4 April 2022

ESC Premium Access

The long non-coding RNA Heat4 is upregulated in heart failure and decreases the immune response of non-classical monocytes

27 August 2021

This platform is supported by

logo Novo Nordisk